SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Claude Deschamps, MD
Mayo Clinic
Study Chair - David H. Johnson, MD
Vanderbilt-Ingram Cancer Center
Study Chair - Lawrence N. Shulman, MD
Dana-Farber Cancer Institute
Study Chair - Ronald L. Burkes, MD, FRCPC
Mount Sinai Hospital, Canada
Study Chair - Valerie W. Rusch, MD, FACS
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 1995
- Primary completion
- 31 Jan 2001
- Completion
- 31 Jul 2004
- Last update posted
- 8 Oct 2012
- Registered enrollment
- 116
- Registry id
- NCT00002642
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.